SAT0145 Timing and magnitude of initial response to certolizumab pegol in a broad population of patients with active rheumatoid arthritis predicts likelihood of LDA at week 28

Abstract

BackgroundIt has previously been shown that the majority of patients (pts) with active rheumatoid arthritis (RA) have a rapid response to certolizumab pegol (CZP) and that lack of improvement in...